158 related articles for article (PubMed ID: 30511133)
1. Benefits of Splenectomy and Curative Treatments for Patients with Hepatocellular Carcinoma and Portal Hypertension: a Retrospective Study.
Pei Y; Chai S; Zhang Y; Zhang Z; Chen X; Zhang W
J Gastrointest Surg; 2019 Nov; 23(11):2151-2162. PubMed ID: 30511133
[TBL] [Abstract][Full Text] [Related]
2. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
[TBL] [Abstract][Full Text] [Related]
3. Splenectomy before hepatectomy for patients with hepatocellular carcinoma and hypersplenism: A retrospective study.
Zhou C; Huang Y; Shu C; Zhou J; Hu X; Wang J; Wang Y; Zhang Z; Chen L; Chen X; Zhang Z
Medicine (Baltimore); 2021 Jan; 100(4):e24326. PubMed ID: 33530224
[TBL] [Abstract][Full Text] [Related]
4. Synchronous hepatectomy and splenectomy vs hepatectomy for selected patients with hepatocellular carcinoma and clinically significant portal hypertension: A systematic review and meta-analysis.
Kong J; Shen S; Wang W
J Surg Oncol; 2019 Jun; 119(7):964-973. PubMed ID: 30775785
[TBL] [Abstract][Full Text] [Related]
5. A preliminary study on surgery for hepatocellular carcinoma patients with portal hypertension.
Duan YF; Li XD; Sun DL; Chen XM; An Y; Zhu F
Am J Surg; 2015 Jul; 210(1):129-33. PubMed ID: 25457251
[TBL] [Abstract][Full Text] [Related]
6. Impact of concurrent splenectomy and esophagogastric devascularization on surgical outcomes of partial hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: A multicenter propensity score matching analysis.
Chen ZL; Yao LQ; Pu JL; Wu H; Xu XF; Chen TH; Zhou YH; Wang H; Chen ZY; Sun LY; Diao YK; Zhong JH; Lau WY; Pawlik TM; Huang DS; Shen F; Liang YJ; Yang T
Eur J Surg Oncol; 2022 May; 48(5):1078-1086. PubMed ID: 34838392
[TBL] [Abstract][Full Text] [Related]
7. [Role of united hepatectomy and splenectomy in the surgical treatment of hepatocellular carcinoma complicated with hepatic cirrhosis and hypersplenism].
Chen XP; Wu ZD; Qiu FZ
Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):442-6. PubMed ID: 15854370
[TBL] [Abstract][Full Text] [Related]
8. Open Radiofrequency Ablation Combined with Splenectomy and Pericardial Devascularization vs. Liver Transplantation for Hepatocellular Carcinoma Patients with Portal Hypertension and Hypersplenism: A Case-Matched Comparative Study.
Wang X; Sun X; Lei Y; Pei J; Ma K; Feng K; Lau WY; Xia F
J Invest Surg; 2023 Dec; 36(1):1-7. PubMed ID: 36345736
[TBL] [Abstract][Full Text] [Related]
9. Morphologic severity of cirrhosis determines the extent of liver resection in patients with hepatocellular carcinoma and Child-Pugh grade A cirrhosis.
Zhou SJ; Zhang EL; Liang BY; Zhang ZY; Dong KS; Hou P; Chen XP; Xiong M; Huang ZY
J Surg Res; 2016 Feb; 200(2):444-51. PubMed ID: 26470819
[TBL] [Abstract][Full Text] [Related]
10. A Novel Technique for Synchronous Laparoscopic Splenectomy and Azygoportal Disconnection With Hepatectomy.
Jiang G; Bai D; Chen P; Qian J; Jin S
Surg Innov; 2018 Jun; 25(3):218-223. PubMed ID: 29529940
[TBL] [Abstract][Full Text] [Related]
11. Combination of albumin-bilirubin grade and clinically significant portal hypertension predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
Qin L; Li C; Xie F; Wang Z; Wen T
Biosci Trends; 2021 Mar; 15(1):41-49. PubMed ID: 33627573
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the risk of hepatic failure in patients with portal vein invasion hepatoma after hepatic resection.
Hsieh CB; Yu CY; Tzao C; Chu HC; Chen TW; Hsieh HF; Liu YC; Yu JC
Eur J Surg Oncol; 2006 Feb; 32(1):72-6. PubMed ID: 16246517
[TBL] [Abstract][Full Text] [Related]
13. Portal hypertension predicts short-term and long-term outcomes after hepatectomy in hepatocellular carcinoma patients.
Zheng YW; Wang KP; Zhou JJ; Zhang ZQ; Xiong L; Wen Y; Zou H
Scand J Gastroenterol; 2018 Dec; 53(12):1562-1568. PubMed ID: 30572742
[TBL] [Abstract][Full Text] [Related]
14. Impact of Splenic Volume and Splenectomy on Prognosis of Hepatocellular Carcinoma Within Milan Criteria After Curative Hepatectomy.
Takeishi K; Kawanaka H; Itoh S; Harimoto N; Ikegami T; Yoshizumi T; Shirabe K; Maehara Y
World J Surg; 2018 Apr; 42(4):1120-1128. PubMed ID: 28920178
[TBL] [Abstract][Full Text] [Related]
15. Splenectomy Followed by Hepatectomy for Hepatocellular Carcinoma with Hypersplenism and Portal Hypertension Caused by Macroglobulinemia.
Hu Q; Takeishi K; Yamashita Y; Ikeda T; Wang H; Itoh S; Harimoto N; Ikegami T; Yoshizumi T; Kawanaka H; Shirabe K; Maehara Y
Anticancer Res; 2015 Jul; 35(7):4077-81. PubMed ID: 26124358
[TBL] [Abstract][Full Text] [Related]
16. Is portal hypertension a contraindication to hepatic resection?
Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; Ramacciato G; Grazi GL; Pinna AD
Ann Surg; 2009 Dec; 250(6):922-8. PubMed ID: 19855258
[TBL] [Abstract][Full Text] [Related]
17. The role of splenectomy in patients with hepatocellular carcinoma and secondary hypersplenism.
Oh JW; Ahn SM; Kim KS; Choi JS; Lee WJ; Kim BR
Yonsei Med J; 2003 Dec; 44(6):1053-8. PubMed ID: 14703616
[TBL] [Abstract][Full Text] [Related]
18. Developmental artificial neural network model to evaluate the preoperative safe limit of future liver remnant volume for HCC combined with clinically significant portal hypertension.
Lu HZ; Mai RY; Wang XB; Chen J; Bai T; Ma L; Xiang BD; Cheng SQ; Guo WX; Li LQ; Ye JZ
Future Oncol; 2022 Jul; 18(21):2683-2694. PubMed ID: 35699041
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of hepatocellular carcinoma in China: surgical techniques, indications, and outcomes.
Chen XP; Huang ZY
Langenbecks Arch Surg; 2005 Jun; 390(3):259-65. PubMed ID: 15875211
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic Liver Surgery: What Are the Advantages in Patients with Cirrhosis and Portal Hypertension? Systematic Review and Meta-Analysis with Personal Experience.
Coletta D; De Padua C; Parrino C; De Peppo V; Oddi A; Frigieri C; Grazi GL
J Laparoendosc Adv Surg Tech A; 2020 Oct; 30(10):1054-1065. PubMed ID: 32707003
[No Abstract] [Full Text] [Related]
[Next] [New Search]
